OneDigital Investment Advisors LLC Invests $615,000 in Cellebrite DI Ltd. (NASDAQ:CLBT)

OneDigital Investment Advisors LLC acquired a new position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm acquired 27,903 shares of the company's stock, valued at approximately $615,000.

Several other hedge funds and other institutional investors have also modified their holdings of CLBT. True Wind Capital Management L.P. raised its holdings in shares of Cellebrite DI by 18.2% during the 4th quarter. True Wind Capital Management L.P. now owns 13,861,007 shares of the company's stock valued at $305,358,000 after buying an additional 2,130,386 shares during the period. FMR LLC lifted its position in shares of Cellebrite DI by 89.1% during the fourth quarter. FMR LLC now owns 10,621,344 shares of the company's stock worth $233,988,000 after purchasing an additional 5,004,587 shares in the last quarter. Voss Capital LP boosted its stake in shares of Cellebrite DI by 1.2% in the fourth quarter. Voss Capital LP now owns 3,240,000 shares of the company's stock valued at $71,377,000 after purchasing an additional 39,700 shares during the period. Pertento Partners LLP grew its holdings in Cellebrite DI by 26.7% during the 4th quarter. Pertento Partners LLP now owns 2,975,374 shares of the company's stock valued at $65,547,000 after purchasing an additional 626,373 shares in the last quarter. Finally, Pembroke Management LTD boosted its position in Cellebrite DI by 4.4% in the 4th quarter. Pembroke Management LTD now owns 1,992,432 shares of the company's stock valued at $43,893,000 after buying an additional 84,087 shares during the last quarter. 45.88% of the stock is owned by institutional investors and hedge funds.

Cellebrite DI Price Performance

Shares of NASDAQ:CLBT traded up $0.62 on Friday, reaching $20.48. 218,952 shares of the company traded hands, compared to its average volume of 1,411,149. The company's 50 day moving average is $18.79 and its 200-day moving average is $20.16. The stock has a market capitalization of $4.90 billion, a PE ratio of -14.72, a P/E/G ratio of 4.27 and a beta of 1.44. Cellebrite DI Ltd. has a fifty-two week low of $10.25 and a fifty-two week high of $26.30.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last posted its quarterly earnings results on Thursday, February 13th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.10 by ($0.03). Cellebrite DI had a positive return on equity of 58.70% and a negative net margin of 70.54%. As a group, analysts expect that Cellebrite DI Ltd. will post 0.3 EPS for the current year.

Wall Street Analyst Weigh In

CLBT has been the subject of a number of research analyst reports. JPMorgan Chase & Co. lifted their price target on shares of Cellebrite DI from $24.00 to $28.00 and gave the stock an "overweight" rating in a research note on Tuesday, February 11th. Lake Street Capital raised their target price on Cellebrite DI from $17.00 to $26.00 and gave the company a "buy" rating in a research note on Friday, February 14th. Finally, Needham & Company LLC reissued a "buy" rating and issued a $28.00 price objective on shares of Cellebrite DI in a report on Wednesday, April 2nd. Seven analysts have rated the stock with a buy rating, According to MarketBeat.com, Cellebrite DI presently has a consensus rating of "Buy" and an average target price of $23.43.

Cellebrite DI Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.